Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Brunelli

Showing results (311-320 of 409) with videos related to

Pageof 41
Sort By:
Oncotarget|August 14, 2018
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263Enrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, et al.
Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.
NPJ Precision Oncology|July 24, 2025
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experienceRiccardo Bertolo, Lorenzo De Bon, Filippo Caudana, et al.
Journal of Clinical Medicine|January 11, 2025
Elderly Prostate Cancer Patients Treated with Robotic Surgery Are More Likely to Harbor Adverse Pathology Features and Experience Disease Progression: Analysis of the Prognostic Impact of Adverse Pathology Risk Score Patterns Using Briganti's 2012 Nomogram and EAU Risk GroupsAntonio Benito Porcaro, Emanuele Serafin, Francesca Montanaro, et al.
Urologia Internationalis|February 15, 2017
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or ProgressionAntonio Benito Porcaro, Francesca Cavicchioli, Nicolò De Luyk, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2018
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysisGiulio Riva, Christine Mian, Claudio Luchini, et al.
Infectious Agents and Cancer|April 1, 2021
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach studyFederica Zito Marino, Rosalaura Sabetta, Francesca Pagliuca, et al.
Oncotarget|January 18, 2019
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
Oncotarget|November 23, 2017
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
Journal of Robotic Surgery|November 27, 2022
American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral centerAntonio Benito Porcaro, Riccardo Rizzetto, Alberto Bianchi, et al.
Pageof 41

Showing results (311-320 of 409) with videos related to

Sort By:
Pageof 41
Oncotarget|August 14, 2018
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263Enrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, et al.
Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.
NPJ Precision Oncology|July 24, 2025
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experienceRiccardo Bertolo, Lorenzo De Bon, Filippo Caudana, et al.
Journal of Clinical Medicine|January 11, 2025
Elderly Prostate Cancer Patients Treated with Robotic Surgery Are More Likely to Harbor Adverse Pathology Features and Experience Disease Progression: Analysis of the Prognostic Impact of Adverse Pathology Risk Score Patterns Using Briganti's 2012 Nomogram and EAU Risk GroupsAntonio Benito Porcaro, Emanuele Serafin, Francesca Montanaro, et al.
Urologia Internationalis|February 15, 2017
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or ProgressionAntonio Benito Porcaro, Francesca Cavicchioli, Nicolò De Luyk, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2018
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysisGiulio Riva, Christine Mian, Claudio Luchini, et al.
Infectious Agents and Cancer|April 1, 2021
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach studyFederica Zito Marino, Rosalaura Sabetta, Francesca Pagliuca, et al.
Oncotarget|January 18, 2019
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
Oncotarget|November 23, 2017
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
Journal of Robotic Surgery|November 27, 2022
American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral centerAntonio Benito Porcaro, Riccardo Rizzetto, Alberto Bianchi, et al.
Pageof 41